The company is scaling up manufacturing and commercial activities as it prepares to enter the U.S. market via the Food and Drug Administration’s de novo pathway.

The global blood collection devices market is set to grow from USD 9.13 billion in 2025 to USD 13.02 billion by 2030, with a CAGR of 7.4%. Factors driving market growth include the increasing ...